Here's why Integrated Research Limited surged 37% today

Software provider Integrated Research Limited (ASX:IRI) has given its shareholders something huge to smile about

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of Integrated Research Limited (ASX: IRI) have taken flight today after the small-cap software provider issued a profit update for its half year results ending 31 December 2014.

While the stock was trading within just one cent of a 52-week low on Wednesday (at 93 cents), it has risen an astonishing 35.5% this morning to be trading at $1.26 – close to a two-year high.

So What: Integrated Research is a leading global provider of proactive performance management software. In a market sensitive announcement released on Wednesday night, the company stated that it expected to deliver strong profit growth in the first-half of the 2015 financial year, forecasting a profit after tax of between $7 million and $8 million.

Based on the $4.5 million recorded in the prior corresponding period, that would reflect profit growth of between 55% and 77%. It also compares to the $8.5 million profit recorded by Integrated for the entire 2014 financial year. The company expects to announce its first-half results on February 19.

The company said that its preliminary results, which included strong sales across all product lines, were influenced by the falling Australian dollar, although the full positive impact was partially offset by forward exchange rate contracts.

Now What: Although it's been a bumpy ride for shareholders over the last couple of years, last night's announcement shows that there is still potential for fantastic growth over the coming years which could lead to enormous shareholder returns.

Before you buy Integrated Research however, there's another ultra-promising stock that needs your immediate attention.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »